Login  

American Society of Clinical Psychopharmacology

ASCP Corner: Reading Reports of Clinical Trial Results

ASCP Corner: Cultural Competence in Clinical Psychopharmacology

ASCP Corner: Challenges and Opportunities in Teaching Psychopharmacology During Residency Training

ASCP Corner: Increased Risk of Cerebrovascular Adverse Events and Death in Elderly Demented Patients Treated With Atypical Antipsychotics: What's a Clinician to Do?

ASCP Corner: Gender Differences in Clinical Psychopharmacology

ASCP Corner: Metabolic Side Effects of Second-Generation Antipsychotics in Children and Adolescents: A Different Story?

ASCP Corner: Sexual Function and Dysfunction During Treatment With Psychotropic Medications

ASCP Corner: Real-Life Dosing With Second-Generation Antipsychotics

ASCP Corner: Real-Life Switching Strategies With Second-Generation Antipsychotics

ASCP Corner: Complex Chemical Concoctions

ASCP Corner: Use of Atypical Antipsychotics: Observations From Clinical Practice

ASCP Corner: Novel Transdermal Delivery Formulation of the Monoamine Oxidase Inhibitor Selegiline Nearing Release for Treatment of Depression

ASCP Corner: Commentary on the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE)

ASCP Corner: Female Sexual Dysfunctions: What Controversy?

ASCP Corner: ASCP Administers 10th Certification Exam.

ASCP Corner: FDA Post-Marketing Safety Decisions

ASCP Corner: Buprenorphine: Reflections of an Addictions Psychiatrist

ASCP Corner: Combining Pharmacotherapy With Psychotherapeutic Management: Guidelines for Integration

ASCP Corner: Measurement-Based Psychiatry: Definitions of Response, Remission, Stability, and Relapse in Schizophrenia

ASCP Corner: The Psychopharmacology of Violence With Emphasis on Schizophrenia, Part 1: Acute Treatment

ASCP Corner: The Psychopharmacology of Violence With Emphasis on Schizophrenia, Part 2: Long-Term Treatment

ASCP Corner: Choice of Antipsychotic in HIV-Infected Patients

ASCP Corner: Psychopharmacologic Treatment Response of HIV-Infected Patients to Antipsychotic Medications

ASCP Corner: Psychopharmacology in the Emergency Room

ASCP Corner: Pharmacoepidemiology: Recent Findings and Challenges for Child and Adolescent Psychopharmacology

ASCP Corner: Dual Dependency on Cocaine and Alcohol in Opiate Addicts: Treatment Options.

ASCP Corner: Clinical Psychopharmacology of Pediatric Mood Stabilizer and Antipsychotic Treatment, Part 1: Challenges and Developments

ASCP Corner: Clinical Psychopharmacology of Pediatric Mood Stabilizer and Antipsychotic Treatment, Part 2: Methodological Considerations

ASCP Corner: Worried Sick: Antidepressants, Stress, and Inflammation

ASCP Corner: Teaching and Practicing Psychopharmacology

ASCP Corner: What Constitutes Evidence-Based Pharmacotherapy for Bipolar Disorder? Part 1: First-Line Treatments

ASCP Corner: State of the Society

ASCP Corner: Balancing Risks: Dosing Strategies for Antidepressants Near the End of Pregnancy

ASCP Corner: What Constitutes Evidence-Based Pharmacotherapy for Bipolar Disorder? Part 2: Complex Presentations and Clinical Context

ASCP Corner: Antipsychotic Polypharmacy, Part 1: Shotgun Approach or Targeted Cotreatment?

ASCP Corner: Antipsychotic Polypharmacy, Part 2: Why Use 2 Antipsychotics When 1 Is Not Good Enough?

ASCP Corner: Are Antidepressants Effective? What’s a Clinician to Think?

ASCP Corner: Are Nutritional Supplements Ready for Prime Time?

ASCP Corner: The Search for Knowledge: Developing the American Psychiatric Association's Practice Guideline for Major Depressive Disorder

ASCP Corner: Qualifications for Recertification: An Important but Evolving Set of Standards

ASCP Corner: Is the Problem of a High Placebo Response Unique to Antidepressant Trials?

ASCP Corner: Why Aren't MAOIs Used More Often?

ASCP Corner: Breastfeeding and Antidepressants: Clinical Dilemmas and Expert Perspectives

ASCP Corner: All Antipsychotics Are Equal, but Some Are More Equal Than Others

ASCP Corner: Second-Generation Antipsychotic-Associated Diabetes Mellitus and Diabetic Ketoacidosis: Mechanisms, Predictors, and Screening Need (ASCP Corner)

ASCP Corner: Adding Lithium or Anticonvulsants to Antipsychotics for the Treatment of Schizophrenia: Useful Strategy or Exercise in Futility?

ASCP Corner: Suicide Risk and Psychopharmacology: Assessment and Management of Acute and Chronic Risk Factors

Genetic Studies of Drug Response and Side Effects in the STAR*D Study, Part 1

ASCP Corner: Genetic Studies of Drug Response and Side Effects in the STAR*D Study, Part 2

Activation Induced by High-Dose Ziprasidone: A Case Report

Do Glutamatergic Agents Represent a New Class of Antidepressant Drugs? Part 1

Do Glutamatergic Agents Represent a New Class of Antidepressant Drugs? Part 2

ASCP Corner: Reconceptualizing Medication Management: Implications for Training and Clinical Practice

How to Efficiently Maintain Your Own Electronic Resource Library

Transcranial Magnetic Stimulation for Medication-Resistant Depression

ASCP Corner: Therapeutic Drug Monitoring in Pregnant and Postpartum Women: Recommendations for SSRIs, Lamotrigine, and Lithium

Tardive Dystonia Due to Aripiprazole Use in a Neuroleptic-Naive Patient

Bereavement, Complicated Grief, and <em>DSM</em>, Part 1: Depression

Bereavement, Complicated Grief, and <em>DSM</em>, Part 2: Complicated Grief

New Antipsychotic Drugs: How Do Their Receptor-Binding Profiles Compare?

Omega-3 Fatty Acids and Depression: From Cellular Mechanisms to Clinical Care

Number Needed to Treat: What It Is and What It Isn’t, and Why Every Clinician Should Know How to Calculate It

ASCP Corner: Rediscovering Adverse Anticholinergic Effects

ASCP Corner: Assessing the Adequacy of Past Antidepressant Trials: A Clinician’s Guide to the Antidepressant Treatment Response Questionnaire

ASCP Corner: Stepping Back to Step Forward: Lessons From the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD)

Risperidone-Induced Dislocation of the Temporomandibular Joint

ASCP Corner: Discordance Between Researchers and Patients in Defining Remission From Depression

Cardiovascular Disease and Bipolar Disorder: Risk and Clinical Implications

ASCP Corner: Monoamine Oxidase Inhibitors Revisited: What You Should Know

ASCP Corner: Reconsidering Chronic Hyponatremia in Psychosis

ASCP Corner: Lessons Learned From <span style="font-variant:small-caps;">d</span>-Cycloserine: The Promise and Limits of Drug Facilitation of Exposure Therapy

ASCP Corner: Current Status of Ketamine and Related Compounds for Depression

ASCP Corner: Bipolar Disorder and Attention-Deficit/Hyperactivity Disorder Comorbidity in Children and Adolescents: Evidence-Based Approach to Diagnosis and Treatment

ASCP Corner: Changes in the Diagnostic Criteria for Autism in <em>DSM-5</em>: Controversies and Concerns

ASCP Corner: Pulsed Intravenous Administration of Scopolamine Produces Rapid Antidepressant Effects and Modest Side Effects

ASCP Corner: Antidepressant Use in Pregnancy and Risk of Autism Spectrum Disorders: A Critical Examination of the Evidence

ASCP Corner: Decision Making and Antipsychotic Medication Treatment for Youth With Autism Spectrum Disorders: Applying Guidelines in the Real World

ASCP Corner: The Role of Vitamin D in Depression: From a Curious Idea to a Therapeutic Option

ASCP Corner: The ASCP Annual Meeting (NCDEU): A History

ASCP Corner: The Endocannabinoid System and Schizophrenia: Links to the Underlying Pathophysiology and to Novel Treatment Approaches

J Clin Psychiatry/Inflammatory Depression: A Trifecta of Trouble

Hoarding Disorder: More Than Just a Problem of Too Much Stuff

Can We Bottle Psychosocial Treatments for Addiction? The Role of Oxytocin

Updates and Trends in the Treatment of Major Depressive Disorder

Bipolar Therapeutics Update 2014: A Tale of 3 Treatments

Improving the Practice of Clinical Psychopharmacotherapy: The Process of Long-Term Management for Patients and Caregivers